ALK Abello A/S : Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
August 31, 2016 at 08:33 am EDT
Share
August 31, 2016
Copenhagen, 2016-08-31 14:26 CEST (GLOBE NEWSWIRE) --
ALK (ALKB:DC/ OMX: ALK B / AKABY / AKBLF) reports the following transactions:
1.
Details of the person discharging managerial responsibility / person closely associated
a)
Name
Andreas Slyngborg Holst
2.
Reason for the notification
a)
Position/status
Member of the Board of Directors (employee-elected)
b)
Initial notification/
amendment
Initial notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
ALK-Abelló A/S
b)
LEI
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument: (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the
financial instrument,
type of instrument
Identification code
Share options
DK0060027142
b)
Nature of the transaction
Purchase (exercise of share options / purchase of shares - cash settlement)
The purchase price is based on the price at grant adjusted upwards annually by 2.5% less dividend payments.
c)
Price(s) and volume(s)
Price(s) Volume(s)
420,741.75 975
d)
Aggregated information
- Aggregated volume
- Price
975 DKK 420,741.75
e)
Date of the transaction
2016-08-30
f)
Place of the transaction
NASDAQ Copenhagen
1.
Details of the person discharging managerial responsibility / person closely associated
a)
Name
Andreas Slyngborg Holst
2.
Reason for the notification
a)
Position/status
Member of the Board of Directors (employee-elected)
b)
Initial notification/
amendment
Initial notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
ALK-Abelló A/S
b)
LEI
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument: (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the
financial instrument,
type of instrument
Identification code
Share options
DK0060027142
b)
Nature of the transaction
Sale (exercise of share options/sale of shares - cash settlement)
The share options will be settled in cash and the final settlement is based on the average price of the Company's B shares quoted on NASDAQ Copenhagen A/S in a period of ten days.
c)
Price(s) and volume(s)
Price(s) Volume(s)
904,995 975
d)
Aggregated information
- Aggregated volume
- Price
975
DKK 904,995
e)
Date of the transaction
2016-08-30
f)
Place of the transaction
NASDAQ Copenhagen
ALK-Abelló A/S
For further information please contact: Investor Relations: Per Plotnikof, tel. +45 4574 7527, mobile +45 2261 2525
Close window | Back to top
ALK-Abelló A/S published this content on 31 August 2016 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 31 August 2016 12:33:08 UTC.
Original documenthttp://ir.alk-abello.com/releasedetail.cfm?ReleaseID=987245
Public permalinkhttp://www.publicnow.com/view/A5E903B45750E8E221EA7F445C9B3FA969947339
ALK-Abello A/S is a Denmark-based company active within the pharmaceutical industry. It is engaged in the development and marketing of pharmaceutical products for the treatment, prevention and diagnosis of allergy. Its product portfolio comprises allergy vaccines, emergency treatments and allergy diagnostics products. The Companyâs allergy vaccines product offering comprises tablet vaccines, sublingual vaccines and subcutaneous vaccines. Its emergency treatments product offering comprises products for the management of anaphylaxis. Its allergy diagnostics product offering comprises allergen extracts for allergy testing, such as skin-prick tests. The Company operates worldwide through subsidiaries, production units and distributors in such countries as Austria, Canada, France, Italy, the Netherlands, Poland, Spain, Switzerland, the United States and China.